-

2022 Bladder Cancer Update Bulletin: Key Opinion Leader (KOL) Views on Recent Developments - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bladder Cancer: Update Bulletin #2" newsletter has been added to ResearchAndMarkets.com's offering.

This edition presents leading key opinion leader (KOL) views on recent developments in the Bladder Cancer market.

Topics covered include: Bristol-Myers Squibb (BMS) presenting positive data from a Phase I/II study investigating a combination of its PD-1 inhibitor Opdivo (nivolumab) with its pipeline indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, BMS-986205, in heavily pretreated patients with advanced bladder cancer; BioCanCell announcing final results for its Phase IIb combination trial investigating its lead compound BC-819 in combination with the BCG vaccine in 38 patients with intermediate-and high-risk non-muscle invasive bladder cancer (NMIBC); KOLs offering their updated opinions on the the supply status of the BCG vaccine in the US and key European markets.

Business Questions:

  • How do the KOLs perceive the Phase II combination results for BMS' Opdivo with the IDO inhibitor BMS-986205 in patients with advanced bladder cancer?
  • Do KOLs view PD-1/PD-L1 and IDO inhibition as a viable combination approach going forward?
  • What are experts' thoughts on PD-L1 expression and its future use as a biomarker in patients with bladder cancer?
  • Do KOLs hold any other concerns about dual immunotherapy combinations such as cost, access or increased risk of toxicity?
  • If approved, how and when would KOLs consider using the combination approach of Opdivo with an IDO inhibitor?
  • Based on published Phase II data, how do the experts view the results so far for BC-819 with BCG in patients with NMIBC?
  • Are the KOLs enthusiastic about intravesical gene therapies as treatments for NMIBC and if so, why?
  • How do the experts perceive the planned Phase III trial investigating BC-819 in patients that are BCG-recurrent?
  • If approved, can BC-819 gain market share in patients with high-risk or intermediate-risk NMIBC?
  • What are KOLs' opinions on the supply shortages previously reported for the BCG vaccine and are they being addressed?

For more information about this newsletter visit https://www.researchandmarkets.com/r/9ke1kl

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Mice Model Market Trends and Growth Opportunities by Segment & Region 2025-2032 - Transformative Innovations in Genetic Engineering Propel Mice Model Research in Oncology and Rare Diseases - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Mice Model Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The mice model market is experiencing robust growth, with projected expansion from USD 1.61 billion in 2024 to USD 3.11 billion by 2032, driven by a compound annual growth rate (CAGR) of 8.60%. This market research report explores the pioneering advances, critical drivers, and significant innovations redefining the landscape of mice model research, particularly in th...

All India Agricultural Commodities Market Intelligence Service: Stay Informed on Price Trends, Production Estimates, and Trade Data for Commodities Like Rice, Wheat, Pulses, and Spices - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "All India Agricultural Commodities Market Intelligence Subscription" report has been added to ResearchAndMarkets.com's offering. India All Agricultural Commodities Market Intelligence Reports contain comprehensive information on Indian Agricultural Markets, including rice, wheat, maize, six major pulses, three oilseeds, three vegetable oils, two oilmeals, sugar, cotton, six major spices, feed ingredients, guarseed, guar gum and castorseed. Includes prices and marke...

Germany Data Center Colocation Market Supply & Demand Analysis Report 2025-2030: Latest Trends, Potential Opportunities, Growth Restraints, and Prospects - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Germany Data Center Colocation Market - Supply & Demand Analysis 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Germany Data Center Colocation Market was valued at USD 2.37 billion in 2024, and is projected to reach USD 5.36 billion by 2030, rising at a CAGR of 14.57%. Germany is one of the major developed data center hubs in Europe, accounting for around 187 existing colocation data center facilities as of December 2024. Frankfurt,...
Back to Newsroom